Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia
Background: CD26 is expressed in all chronic myeloid leukemia (CML) patients. This study investigated the role of CD26+ LSCs in diagnosis and follow up of CML patients. Method: Flow cytometry was performed to evaluate CD26+ LSC in peripheral blood (PB) in CML patients. BCR-ABL1 transcript level meas...
Main Authors: | Huda F Ebian, AL-Shabrawy M. Abdelnabi, Abdallah S. Abdelazem, Tarek Khamis, Hebatallah M. Fawzy, Samia Hussein |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048922000334 |
Similar Items
-
CD26/DPP-4 in Chronic Myeloid Leukemia
by: Anna Sicuranza, et al.
Published: (2022-02-01) -
Atypical presentation of chronic myeloid leukemia with visual disturbance
by: Rachana Chennamaneni, et al.
Published: (2018-01-01) -
The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia
by: Alessandro Costa, et al.
Published: (2023-07-01) -
Update in Childhood Chronic Myeloid Leukemia
by: Fiorina Giona, et al.
Published: (2022-11-01) -
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
by: Kamal Chamoun, et al.
Published: (2019-01-01)